Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Feb 14, 2022 12:47pm
168 Views
Post# 34426685

RE:Will they release pk data re 4050 they said results are so b

RE:Will they release pk data re 4050 they said results are so b

Bingo, Ed. This scenario seems to be playing out. When they removed IPF from clinical trial planning in May 2021 and said that they would need until end of 2021 (another 7 months) to see if there is any potential left in 4050, we could almost guarantee that Thomvest is burying 4050. Now, they have extended the time they need to find a 4050 indication until mid 2022 while burning cash at their alarming rate. It becomes obvious that they will run out of money without being able to do a trial or just announce that results were quite strong enough in a one line press release this June. However, the deal with Pierre suggests that they need that deal cleaned up before selling 4050 after thomvest take it private. 

edrose wrote: Bad they decided to put further research re 4050 on hold 
then they turn around and make deal and pay pierre laurin for parent molecule of 4050 
If 4050 is worthless like they want us to believe WHY PAY pierre laurin for 1402 

4050 had great results in other studies and there was never serious issues or mention re pk data 

who will the judge believe after information is released 

 

<< Previous
Bullboard Posts
Next >>